Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 2, 2005, Pages 1035-1040

  Poynten, Ann M ^a,b   Gan, S K ^a   Kriketos, A D ^a   Campbell, L V ^a   Chisholm, D J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; CALORIMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; LIPID OXIDATION; LIPID STORAGE; LIPOLYSIS; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; VOLUNTEER;

ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN; LIPOPROTEINS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; REFERENCE VALUES; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 14044251609     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0943     Document Type: Article

References (47)

1. Furier SM, Poynten AM, Kriketos AD, Lowy AJ, Ellis BA, Maclean EL, Courtenay BG, Kraegen EW, Campbell LV, Chisholm DJ 2001 Independent influences of central fat and skeletal muscle lipids on insulin sensitivity. Obes Res 9:535-543
2. Gan SK, Kriketos AD, Poynten AM, Furler SM, Thompson CH, Kraegen EW, Campbell LV, Chisholm DJ 2003 Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res 11:1295-1305
3. Kriketos AD, Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV 2003 Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab 88:793-798
4. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF 2002 The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797-802
5. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR 2003 Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol 285:E354-E362
6. Kissebah AH, Alfarsi S, Adams PW, Wynn V 1976 Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12:563-571
7. Hennes MM, Dua A, Kissebah AH1997 Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46:57-62
8. Baient B, Goswami G, Goodloe G, Rogatsky E, Rauta O, Nezami R, Mints L, Angeletti RH, Stein DT 2002 Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann NY Acad Sci 967:535-543
9. Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, Golden SH 2004 Fasting plasma free fatty acids and risk of type 2 diabetes. Diabetes Care 27:77-82
10. Homko CJ, Cheung P, Boden G 2003 Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 52:487-491
11. Ilani SI, Ruderman NB, Schmieder F, Boden G 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011
12. Kelley DE, Goodpaster B, Wing RR, Simoneau JA 1999 Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141
13. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA 2003 Skeletal muscle lipid metabolism with obesity. Am J Physiol 284:E741-E747
14. Poynten AM, Markovic TP, Maclean EL, Furier SM, Freund J, Chisholm DJ, Campbell LV 2003 Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss. Int J Obes Relat Metab Disord 27:1212-1218
15. Sorensen MB, Rosenfalck AM, Hojgaard L, Ottesen B 2001 Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 9:622-626
16. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
17. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
18. Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, Groop L 2004 Parallel manifestation of insulin resistance and β cell decompensation is compatible with a common defect in type 2 diabetes. Diabetologia 47:782-793
19. O'Sullivan AJ, Kelly JJ, Hoffman DM, Baxter RC, Ho KK 1995 Energy metabolism and substrate oxidation in acromegaly. J Clin Endocrinol Metab 80:486-491
20. Ferrannini E 1988 The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301
21. Jones PJ, Schoeller DA 1988 Polyunsaturated:saturated ratio of diet fat influences energy substrate utilization in the human. Metabolism 37:145-151
22. Jensen MD, Kanaley JA, Reed JE, Sheedy PF 1995 Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 61:274-278
23. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ 1996 Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638
24. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
25. Lapsys NM, Kriketos AD, Lim-Fraser M, Poynten AM, Lowy A, Furler SM, Chisholm DJ, Cooney GJ 2000 Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor agamma; expression in human skeletal muscle. J Clin Endocrinol Metab 85:4293-4297
26. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E 1995 A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213-1217
27. Baldeweg SE, Golay A, Natali A, Balkan B, Del Prato S, Coppack SW 2000 Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest 30:45-52
28. Pirro M, Mauriege P, Tchernof A, Cantin B, Dagenais GR, Despres JP, Lamarche B 2002 Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis 160:377-384
29. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P 1998 Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41:1343-1354
30. Van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, Arner P 2002 Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51:2029-2036
31. Poynten AM, Gan SK, Kriketos AD, O'Sullivan A, Kelly JJ, Ellis BA, Chisholm DJ, Campbell LV 2003 Nicotinic acid-induced insulin resistance is related to increased circulating fatty adds and fat oxidation but not muscle lipid content. Metabolism 52:699-704
32. Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL 2001 Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 86:5412-5419
33. Frayn KN 2002 Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201-1210
34. Randle PJ, Priestman DA, Mistry SC, Halsall A 1994 Glucose fatty acid interactions and the regulation of glucose disposal. J Cell Biochem 55:1-11
35. Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA 1987 Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350
36. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U 1996 Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45:947-953
37. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET 2001 Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 24:925-932
38. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ 2003 Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care 26:1706-1713
39. Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad MF, Selby JV, Bergman R, Savage P 2004 Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27:781-787
40. Williams K, Sniderman AD, Sattar N, D'Agostino Jr R, Wagenknecht LE, Haffner SM 2003 Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 108:2312-2316
41. Cowie CC, Howard BV, Harris MI 1994 Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population. Circulation 90:1185-1193
42. Packard CJ, Saito Y 2004 Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 11:6-14
43. Bittner V 2004 Non-high-density lipoprotein cholesterol: an alternate target for lipid-lowering therapy. Prev Cardiol 7:122-126
44. Chan DC, Watts GF, Barrett PH, O'Neill FH, Thompson GR 2003 Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Obes Res 11:591-596
45. Ginsberg HN 2000 Insulin resistance and cardiovascular disease. J Clin Invest 106:453-458
46. Laudes M, Barroso I, Luan J, Soos MA, Yeo G, Meirhaeghe A, Logie L, Vidal-Puig A, Schafer AJ, Wareham NJ, O'Rahilly S 2004 Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Diabetes 53:842-846
47. Howard BV 1993 Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians. Diabetes Care 16:284-291